Insiders Tarsus Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 17/05/2024 BST			5-day change	1st Jan Change
38.24 ^USD	-0.88%		+12.34%	+88.84%

05-15	Transcript : Tarsus Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:55 PM
05-09	Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating	MT

Tarsus Pharmaceuticals, Inc. Announces Executive Changes	01-18	CI
Tarsus Pharmaceuticals Insider Sold Shares Worth $810,623, According to a Recent SEC Filing	12-22	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $136,286, According to a Recent SEC Filing	12-01	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $136,270, According to a Recent SEC Filing	12-01	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $146,933, According to a Recent SEC Filing	11-17	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $105,920, According to a Recent SEC Filing	20/10/23	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $137,680, According to a Recent SEC Filing	22/09/23	MT
Insider Sell: Tarsus Pharmaceuticals	25/08/23	MT
Insider Sell: Tarsus Pharmaceuticals	21/07/23	MT
Insider Sell: Tarsus Pharmaceuticals	14/07/23	MT
Insider Sell: Tarsus Pharmaceuticals	16/06/23	MT
Insider Sell: Tarsus Pharmaceuticals	12/05/23	MT
Insider Sell: Tarsus Pharmaceuticals	03/05/23	MT
Tarsus Pharmaceuticals, Inc. Appoints Jeff Farrow as Chief Strategy Officer	24/04/23	CI
Tarsus Pharmaceuticals Names Jeff Farrow as Chief Financial Officer	24/04/23	MT
Insider Sell: Tarsus Pharmaceuticals	21/04/23	MT
Insider Sell: Tarsus Pharmaceuticals	13/02/23	MT
Tarsus Pharmaceuticals, Inc. Announces Board Changes	07/12/22	CI
Insider Sell: Tarsus Pharmaceuticals	17/11/22	MT
Insider Sell: Tarsus Pharmaceuticals	14/11/22	MT

No results for this search